Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Allbirds Reports First Quarter 2024 Financial Results
-
Iridex to Report First Quarter 2024 Financial Results on May 14, 2024
-
Crinetics Pharmaceuticals to Present Advancements from Atumelnant (CRN04894) and Paltusotine Development Programs at ENDO 2024
-
SuRo Capital Corp. Reports First Quarter 2024 Financial Results
-
Vaxcyte Reports First Quarter 2024 Financial Results and Provides Business Update
-
Sana Biotechnology Reports First Quarter 2024 Financial Results and Business Updates
-
Noodles & Company Announces First Quarter 2024 Financial Results
-
ACV Announces First Quarter 2024 Results
-
ZimVie Reports First Quarter 2024 Financial Results
-
Jamf Releases First Quarter 2024 Financial Results
-
Lulus Reports First Quarter 2024 Results
-
LiveRamp to Discuss Fourth Quarter and Fiscal Year Results
-
red violet Announces First Quarter 2024 Financial Results
-
ACV’s Data-Driven Solutions Drive Profits and Optimize Inventory for Dealerships
-
Maravai LifeSciences Reports First Quarter 2024 Financial Results
-
DoubleDown Interactive Reports First Quarter 2024 Financial Results
-
Jones Soda Sets First Quarter 2024 Conference Call for Tuesday, May 14, 2024, at 4:30 p.m. ET
-
TEN Ltd. Declares Dividend on its Series E Cumulative Perpetual Preferred Shares
-
Assembly Biosciences Reports First Quarter 2024 Financial Results and Recent Highlights
-
Amplify Energy Announces First Quarter 2024 Results and Improved 2024 Guidance
-
Full House Resorts Announces First Quarter Results
-
Tarsus Reports First Quarter 2024 Financial Results and Recent Business Achievements
-
Design Therapeutics Announces First Quarter 2024 Financial Results and Highlights Upcoming Program Milestones
-
Alector Reports First Quarter 2024 Financial Results and Provides Business Update
-
The RealReal Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
-
89bio to Participate in the BofA Securities 2024 Health Care Conference
-
Oculis Announces Completion of Enrollment in Phase 2 Randomized Controlled ACUITY Trial with OCS-05 for Acute Optic Neuritis
-
Prospect Capital Announces March 2024 Financial Results and Declares 84th Consecutive $0.06 Dividend
-
Seer Launches New Technology Access Center in Europe to Expand Accessibility to Unbiased Proteomic Solutions
-
Revolution Medicines Reports First Quarter 2024 Financial Results and Update on Corporate Progress
-
HighPeak Energy, Inc. Announces First Quarter 2024 Financial and Operating Results
-
Olema Oncology Reports First Quarter 2024 Financial Results and Provides Corporate Update
-
Green Thumb Industries Reports First Quarter 2024 Results
-
Monroe Capital Corporation BDC Announces First Quarter 2024 Results
-
Sunrun Reports First Quarter 2024 Financial Results
-
Standard BioTools Reports First Quarter 2024 Financial Results
-
EMCORE Reports Fiscal 2024 Second Quarter Results
-
NV5 Announces First Quarter Results and Raises Guidance
-
Bionano Reports First Quarter 2024 Results and Highlights Recent Business Progress
-
SLR Investment Corp. Announces Quarter Ended March 31, 2024 Financial Results
-
Sunrun’s ‘CalReady’ Power Plant Supports California’s Grid with 16,200 Home Solar-Plus-Storage Systems
-
Xenon Pharmaceuticals to Present at the BofA Securities Health Care Conference 2024
-
LENZ Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updates
-
Howard Hughes Holdings Inc. Reports First Quarter 2024 Results
-
CSX Corporation Declares Quarterly Dividend
-
Duolingo Reports 45% Revenue Growth and Record Profitability in First Quarter 2024; Raises Full Year Guidance
-
Erasca Reports First Quarter 2024 Business Updates and Financial Results
-
Cytokinetics Reports First Quarter 2024 Financial Results
-
CRISPR Therapeutics Provides Business Update and Reports First Quarter 2024 Financial Results
-
Asure Software Sets May & June 2024 Investor Conference Schedule


